Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial - PubMed (original) (raw)

Randomized Controlled Trial

Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial

Pilar Galan et al. BMJ. 2010.

Abstract

Objective: To investigate whether dietary supplementation with B vitamins or omega 3 fatty acids, or both, could prevent major cardiovascular events in patients with a history of ischaemic heart disease or stroke.

Design: Double blind, randomised, placebo controlled trial; factorial design.

Setting: Recruitment throughout France via a network of 417 cardiologists, neurologists, and other physicians.

Participants: 2501 patients with a history of myocardial infarction, unstable angina, or ischaemic stroke.

Intervention: Daily dietary supplement containing 5-methyltetrahydrofolate (560 μg), vitamin B-6 (3 mg), and vitamin B-12 (20 μg) or placebo; and containing omega 3 fatty acids (600 mg of eicosapentanoic acid and docosahexaenoic acid at a ratio of 2:1) or placebo. Median duration of supplementation was 4.7 years.

Main outcome measures: Major cardiovascular events, defined as a composite of non-fatal myocardial infarction, stroke, or death from cardiovascular disease.

Results: Allocation to B vitamins lowered plasma homocysteine concentrations by 19% compared with placebo, but had no significant effects on major vascular events (75 v 82 patients, hazard ratio, 0.90 (95% confidence interval 0.66 to 1.23, P=0.50)). Allocation to omega 3 fatty acids increased plasma concentrations of omega 3 fatty acids by 37% compared with placebo, but also had no significant effect on major vascular events (81 v 76 patients, hazard ratio 1.08 (0.79 to 1.47, P=0.64)).

Conclusion: This study does not support the routine use of dietary supplements containing B vitamins or omega 3 fatty acids for prevention of cardiovascular disease in people with a history of ischaemic heart disease or ischaemic stroke, at least when supplementation is introduced after the acute phase of the initial event.

Trial registration: Current Controlled Trials ISRCTN41926726.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi\_disclosure.pdf and declare that they have no relationships with companies that might have an interest in the submitted work in the previous 3 years; they have no other relationships or activities that could appear to have influenced the submitted work.

Figures

None

Fig 1 Flow chart of study participants.

None

Fig 2 Effect of dietary supplementation with B vitamins on cardiovascular events and mortality (adjusted for age and sex)

None

Fig 3 Kaplan-Meier curves for cumulative incidence of first major cardiovascular event (non-fatal myocardial infarction, ischaemic stroke, or death from cardiovascular disease) associated with dietary supplementation with B vitamins (top) or omega 3 fatty acids (bottom)

None

Fig 4 Effect of dietary supplementation with omega 3 fatty acids on cardiovascular events and mortality (adjusted for age and sex)

Similar articles

Cited by

References

    1. Morrison HI, Schaubel D, Desmeules M, Wigle DT. Serum folate and risk of fatal coronary heart disease. JAMA 1996;275:1893-6. - PubMed
    1. Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998;279:359-64. - PubMed
    1. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002;287:1815-21. - PubMed
    1. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346:1113-8. - PubMed
    1. Erkkilä AT, Lehto S, Pyörälä K, Uusitupa MI. n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease. Am J Clin Nutr 2003;78:65-71. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources